Notably, patients with global loss-of-function mutations in Prkar1a develop peripheral nerve tumours and display a wide range of cardiovascular comorbidities that are often fatal, including dysregulated maintenance of blood pressure, cardiomyopathies and arrhythmia60. Here, PRKAR1A is linked to cardiomyopathy.